Lessening Dyskinesia With Duodopa Linked to Better Quality of Life

Lessening Dyskinesia With Duodopa Linked to Better Quality of Life

311693

Lessening Dyskinesia With Duodopa Linked to Better Quality of Life

By lessening the involuntary movements, called dyskinesia, experienced by people with advanced Parkinson’s disease, treatment with AbbVie’s Duodopa (levodopa-carbidopa intestinal gel) was linked with better health-related quality of life, according to a post-hoc analysis of a clinical trial. Duodopa treatment also was tied to other added benefits, namely easing of pain, the analysis found, citing “long-term, real-world data.” These results were reported in a poster titled “Dyskinesia, Pain, and Quality of Life in Parkinson’s Disease:…

You must be logged in to read/download the full post.